These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 24440599)

  • 41. Biochemical, Epigenetic, and Metabolic Approaches to Target IDH Mutations in Acute Myeloid Leukemia.
    Fathi AT; Wander SA; Faramand R; Emadi A
    Semin Hematol; 2015 Jul; 52(3):165-71. PubMed ID: 26111463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia.
    Ashraf S; Noguera NI; Di Giandomenico J; Zaza S; Hasan SK; Lo-Coco F
    Ann Hematol; 2013 Oct; 92(10):1319-23. PubMed ID: 23949315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.
    Quek L; David MD; Kennedy A; Metzner M; Amatangelo M; Shih A; Stoilova B; Quivoron C; Heiblig M; Willekens C; Saada V; Alsafadi S; Vijayabaskar MS; Peniket A; Bernard OA; Agresta S; Yen K; MacBeth K; Stein E; Vassiliou GS; Levine R; De Botton S; Thakurta A; Penard-Lacronique V; Vyas P
    Nat Med; 2018 Aug; 24(8):1167-1177. PubMed ID: 30013198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flt3 is dispensable to the Hoxa9/Meis1 leukemogenic cooperation.
    Morgado E; Albouhair S; Lavau C
    Blood; 2007 May; 109(9):4020-2. PubMed ID: 17202314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndromes and malignant transformation: where the twain shall meet.
    Bhagwat N; Levine RL
    Sci Transl Med; 2010 Oct; 2(54):54ps50. PubMed ID: 20962328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IDH1 mutation contributes to myeloid dysplasia in mice by disturbing heme biosynthesis and erythropoiesis.
    Gu Y; Yang R; Yang Y; Zhao Y; Wakeham A; Li WY; Tseng A; Leca J; Berger T; Saunders M; Fortin J; Gao X; Yuan Y; Xiao L; Zhang F; Zhang L; Gao G; Zhou W; Wang Z; Mak TW; Ye J
    Blood; 2021 Feb; 137(7):945-958. PubMed ID: 33254233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plk1 regulates mutant IDH1 enzyme activity and mutant IDH2 ubiquitination in mitosis.
    Saikiran Reddy M; Bhattacharjee D; Jain N
    Cell Signal; 2022 Apr; 92():110279. PubMed ID: 35143931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular pathogenesis of AML: translating insights to the clinic.
    Levine RL
    Best Pract Res Clin Haematol; 2013 Sep; 26(3):245-8. PubMed ID: 24309525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cells.
    Gruber E; So J; Lewis AC; Franich R; Cole R; Martelotto LG; Rogers AJ; Vidacs E; Fraser P; Stanley K; Jones L; Trigos A; Thio N; Li J; Nicolay B; Daigle S; Tron AE; Hyer ML; Shortt J; Johnstone RW; Kats LM
    Cell Rep; 2022 Aug; 40(7):111182. PubMed ID: 35977494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120.
    Birendra KC; DiNardo CD
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):460-5. PubMed ID: 27245312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isocitrate dehydrogenase mutations in myeloid malignancies.
    Medeiros BC; Fathi AT; DiNardo CD; Pollyea DA; Chan SM; Swords R
    Leukemia; 2017 Feb; 31(2):272-281. PubMed ID: 27721426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia.
    Kühn MW; Song E; Feng Z; Sinha A; Chen CW; Deshpande AJ; Cusan M; Farnoud N; Mupo A; Grove C; Koche R; Bradner JE; de Stanchina E; Vassiliou GS; Hoshii T; Armstrong SA
    Cancer Discov; 2016 Oct; 6(10):1166-1181. PubMed ID: 27535106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches.
    Gruber E; Kats LM
    Biochem Soc Trans; 2023 Aug; 51(4):1675-1686. PubMed ID: 37526143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia.
    Ragon BK; DiNardo CD
    Curr Hematol Malig Rep; 2017 Dec; 12(6):537-546. PubMed ID: 29064021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-based design, synthesis and bioactivity evaluation of macrocyclic inhibitors of mutant isocitrate dehydrogenase 2 (IDH2) displaying activity in acute myeloid leukemia cells.
    Che J; Huang F; Zhang M; Xu G; Qu B; Gao J; Chen B; Zhang J; Ying H; Hu Y; Hu X; Zhou Y; Gao A; Li J; Dong X
    Eur J Med Chem; 2020 Oct; 203():112491. PubMed ID: 32679449
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IDH mutations in glioma and acute myeloid leukemia.
    Dang L; Jin S; Su SM
    Trends Mol Med; 2010 Sep; 16(9):387-97. PubMed ID: 20692206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
    So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
    Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML.
    Wang Y; Krivtsov AV; Sinha AU; North TE; Goessling W; Feng Z; Zon LI; Armstrong SA
    Science; 2010 Mar; 327(5973):1650-3. PubMed ID: 20339075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dnmt3a loss and Idh2 neomorphic mutations mutually potentiate malignant hematopoiesis.
    Zhang X; Wang X; Wang XQD; Su J; Putluri N; Zhou T; Qu Y; Jeong M; Guzman A; Rosas C; Huang Y; Sreekumar A; Li W; Goodell MA
    Blood; 2020 Mar; 135(11):845-856. PubMed ID: 31932841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.